Clinical Trial Update: R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares R-CHOP with R-CDOP as first-line therapy in elderly patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CDOP
• R-CHOP

Snippet

Sponsor: Wenqi Jiang | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: UNKNOWN